Skip to main content
Notice2026-22820

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
November 9, 2026

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 215 (Monday, November 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 215 (Monday, November 9, 2026)]
[Notices]
[Pages 70887-70888]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-22820]



[[Page 70887]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-27-1461]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Overdose Response Strategy Data 
Collection'' to the Office of Management and Budget (OMB) for review 
and approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on August 20, 
2026, to obtain comments from the public and affected agencies. CDC 
received four public comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Overdose Response Strategy Data Collection (OMB Control No. 0920--
1461. Exp. 8/31/2028)--Revision--National Center for Injury Prevention 
and Control (NCIPC), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Drug overdose death rates, including those involving synthetic 
opioids (such as fentanyl) and stimulants (such as cocaine and 
methamphetamine) rose over the past several decades in the United 
States, becoming a topic of national importance. Drug overdoses remain 
the leading cause of injury-related death in the United States. CDC 
predicts that around 67,000 Americans died from a drug overdose in the 
12-month period ending April 2026.
    The Overdose Response Strategy (ORS) is a unique collaboration 
between public health and public safety agencies designed to help local 
communities reduce drug overdoses and save lives by sharing timely 
data, pertinent intelligence, and evidence-based and innovative 
strategies.
    ORS teams support public health and public safety entities in their 
jurisdictions by:
    <bullet> Sharing data systems to inform rapid and effective 
community overdose prevention efforts.
    <bullet> Supporting immediate, evidence-based response efforts that 
can directly reduce overdose deaths.
    <bullet> Designing and using promising strategies at the 
intersection of public health and public safety.
    <bullet> Disseminating information to support the implementation of 
evidence-informed overdose prevention strategies.
    As the ORS is one of CDC's flagship overdose prevention programs, 
and partnering with public safety is one of CDC's key overdose 
prevention strategies, a greater understanding of the impact and 
effectiveness of the ORS is needed to inform program enhancements and 
improvements.
    This ICR focuses on a survey and a reporting tool that ORS teams 
and their partners will complete to provide critical data to CDC for 
program monitoring, to inform technical assistance and guidance 
documents produced by CDC or other partners, and to assess the extent 
to which the ORS program is achieving the goal of supporting public 
health and public safety partnerships to reduce drug overdose. It will 
also provide CDC with the capacity to respond in a timely manner to 
requests for information about the program from the Department of 
Health and Human Services (HHS), the White House, Congress, and other 
sources. Information collected will be disseminated to ORS teams and to 
the public via an annual Program Evaluation Report and an ORS Annual 
Report. Data from both reports will largely be used to develop 
programmatic reports, tools, and implementation guides for the purposes 
of program improvement.
    We are requesting changes to the approved OMB data collection 
instruments and updating the approved data collection instruments to 
align with the program's updated logic model and evaluation questions, 
which resulted from strategic planning activities and evaluation 
planning activities carried out in 2025 and 2026. Revisions requested 
are to update the logic model, revise and streamline surveys to better 
align with updated logic model, and to update data collection and 
analysis by combining previously approved surveys. These changes are 
expected to significantly improve the efficiency and utility of the 
data collection activities. Based on these changes, CDC requests OMB 
approval for a reduction in annual burden from 653 hours to 327 hours. 
There is no cost to respondents other than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
ORS Respondents.......................  Invitation email........             262               1            2/60

[[Page 70888]]

 
ORS Respondents.......................  Reminder email..........             262               1            2/60
ORS Public Health Analysts............  ORS Annual Evaluation                 61               1           15/60
                                         Survey.                              61               4           30/60
                                        ORS Quarterly Reporting
                                         Template.
ORS Drug Intelligence Officers........  ORS Annual Evaluation                 61               1           15/60
                                         Survey.                              61               4           30/60
                                        ORS Quarterly Reporting
                                         Template.
Public health and public safety         ORS Annual Evaluation                140               1           15/60
 partners.                               Survey.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2026-22820 Filed 11-6-26; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on November 9, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.